Dermapharm Holding SE (DMP) — Cash Flow-to-Debt Ratio
Dermapharm Holding SE (DMP) has a Cash Flow-to-Debt Ratio of 0.03x as of March 2026, meaning its operating cash flow of €39.49 Million could theoretically repay 0% of its total liabilities (€1.54 Billion) in one year. Explore Dermapharm Holding SE (DMP) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dermapharm Holding SE Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Dermapharm Holding SE across 12 annual periods. Also explore how large is Dermapharm Holding SE's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dermapharm Holding SE (2014–2025)
Year-by-year debt coverage analysis for Dermapharm Holding SE. For market capitalisation and broader financial context, see how much is Dermapharm Holding SE worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | €181.51 Million | €1.50 Billion | ▼ -11.7% |
| 2024 | 0.14x | €201.38 Million | €1.47 Billion | ▲ +0.8% |
| 2023 | 0.14x | €219.42 Million | €1.62 Billion | ▼ -58.6% |
| 2022 | 0.33x | €288.53 Million | €880.34 Million | ▲ +18.8% |
| 2021 | 0.28x | €250.37 Million | €907.13 Million | ▲ +89.4% |
| 2020 | 0.15x | €131.10 Million | €899.81 Million | ▲ +10.1% |
| 2019 | 0.13x | €100.61 Million | €760.38 Million | ▼ -62.7% |
| 2018 | 0.35x | €159.13 Million | €448.50 Million | ▲ +39.7% |
| 2017 | 0.25x | €86.74 Million | €341.62 Million | ▼ -17.0% |
| 2016 | 0.31x | €76.78 Million | €250.89 Million | ▲ +91.2% |
| 2015 | 0.16x | €40.38 Million | €252.22 Million | ▼ -12.5% |
| 2014 | 0.18x | €54.26 Million | €296.59 Million | — |